White blood cells, also known as leukocytes, are an important part of the body’s immune system. They are responsible for fighting off infection and disease, and they can be found in many different fluids, including urine. When white blood cells are found in urine, it can be a sign of a urinary tract infection (UTI) or even a more serious condition. In this article, we will take a closer look at white blood cells in urine, exploring the causes and treatments associated with this condition.
White blood cells are part of the body’s immune system and are responsible for fighting off infection and disease. They are produced in the bone marrow and then released into the bloodstream. They are essential for the body’s defense against infection and disease. White blood cells are also found in other body fluids, such as urine, where they can help to detect and treat infections.
White blood cells in urine can be caused by a variety of different conditions, ranging from a simple urinary tract infection to more serious conditions such as kidney disease or cancer. A urinary tract infection (UTI) is the most common cause of white blood cells in urine. A UTI is an infection of the urinary tract, which includes the kidneys, ureters, bladder, and urethra. UTIs are usually caused by bacteria, such as E. coli, and can cause symptoms such as pain or burning when urinating, an increased urge to urinate, and cloudy or bloody urine. Other potential causes of white blood cells in urine include kidney disease, bladder cancer, and sexually transmitted infections (STIs). Kidney disease is a condition in which the kidneys are not able to filter waste and toxins from the body. Bladder cancer is a type of cancer that affects the bladder, and STIs are infections that are spread through sexual contact.
If white blood cells are found in urine, it is important to get a proper diagnosis. A doctor will typically take a urine sample and analyze it for the presence of white blood cells. In some cases, a doctor may also order additional tests, such as a urine culture or imaging tests, to help diagnose the cause of the white blood cells. Once the cause of the white blood cells in urine has been identified, the doctor can recommend the appropriate treatment. For a UTI, the doctor may prescribe antibiotics to fight the infection. If the cause is kidney disease, the doctor may recommend lifestyle changes, such as reducing sodium and increasing water intake, or medications to help control the condition. For bladder cancer, the doctor may recommend surgery or chemotherapy.
White blood cells in urine can be a sign of a variety of different conditions, ranging from a simple urinary tract infection to more serious conditions such as kidney disease or cancer. It is important to get a proper diagnosis to determine the cause of the white blood cells in urine, and then the doctor can recommend the appropriate treatment. With the right diagnosis and treatment, white blood cells in urine can be managed and treated effectively.
1.
Is Exercise an Effective Treatment for Prostate Cancer?
2.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
3.
A promising medication could slow brain tumors in children.
4.
CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group
5.
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer
1.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
2.
Immune Escape Landscapes in Solid Tumors
3.
Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer
4.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
5.
Unlocking the Power of Cryoprecipitate: A Comprehensive Guide
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation